TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, anti… Read more
TTK Healthcare Limited (TTKHLTCARE) - Net Assets
Latest net assets as of September 2025: ₹10.85 Billion INR
Based on the latest financial reports, TTK Healthcare Limited (TTKHLTCARE) has net assets worth ₹10.85 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹12.96 Billion) and total liabilities (₹2.10 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹10.85 Billion |
| % of Total Assets | 83.75% |
| Annual Growth Rate | 18.44% |
| 5-Year Change | 261.47% |
| 10-Year Change | 681.9% |
| Growth Volatility | 40.04 |
TTK Healthcare Limited - Net Assets Trend (2005–2025)
This chart illustrates how TTK Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for TTK Healthcare Limited (2005–2025)
The table below shows the annual net assets of TTK Healthcare Limited from 2005 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹10.65 Billion | +6.41% |
| 2024-03-31 | ₹10.01 Billion | +4.99% |
| 2023-03-31 | ₹9.53 Billion | +189.23% |
| 2022-03-31 | ₹3.30 Billion | +11.87% |
| 2021-03-31 | ₹2.95 Billion | +18.34% |
| 2020-03-31 | ₹2.49 Billion | -0.97% |
| 2019-03-31 | ₹2.51 Billion | +7.92% |
| 2018-03-31 | ₹2.33 Billion | +54.46% |
| 2017-03-31 | ₹1.51 Billion | +10.73% |
| 2016-03-31 | ₹1.36 Billion | +15.17% |
| 2015-03-31 | ₹1.18 Billion | +10.61% |
| 2014-03-31 | ₹1.07 Billion | +8.86% |
| 2013-03-31 | ₹982.22 Million | +11.99% |
| 2012-03-31 | ₹877.03 Million | +15.80% |
| 2011-03-31 | ₹757.35 Million | +17.10% |
| 2010-03-31 | ₹646.73 Million | +4.15% |
| 2009-03-31 | ₹620.96 Million | +8.33% |
| 2008-03-31 | ₹573.23 Million | +19.34% |
| 2007-03-31 | ₹480.31 Million | +31.58% |
| 2006-03-31 | ₹365.03 Million | +1.21% |
| 2005-03-31 | ₹360.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to TTK Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3091.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹9.40 Billion | 88.27% |
| Common Stock | ₹141.30 Million | 1.33% |
| Other Comprehensive Income | ₹1.01 Billion | 9.48% |
| Other Components | ₹98.25 Million | 0.92% |
| Total Equity | ₹10.65 Billion | 100.00% |
TTK Healthcare Limited Competitors by Market Cap
The table below lists competitors of TTK Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
M.R.M. SA
PA:MRM
|
$31.86 Million |
|
GTS Internasional Tbk PT
JK:GTSI
|
$31.86 Million |
|
Kian Shen Corp
TW:1525
|
$31.87 Million |
|
SEG International Bhd
KLSE:9792
|
$31.88 Million |
|
OnMobile Global Limited
NSE:ONMOBILE
|
$31.84 Million |
|
Panca Budi Idaman Tbk PT
JK:PBID
|
$31.84 Million |
|
Alvotech Warrant
NASDAQ:ALVOW
|
$31.83 Million |
|
DSAQU
PINK:DSAQU
|
$31.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TTK Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,009,189,000 to 10,650,482,000, a change of 641,293,000 (6.4%).
- Net income of 816,569,000 contributed positively to equity growth.
- Dividend payments of 141,303,000 reduced retained earnings.
- Other comprehensive income decreased equity by 13,846,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹816.57 Million | +7.67% |
| Dividends Paid | ₹141.30 Million | -1.33% |
| Other Comprehensive Income | ₹-13.85 Million | -0.13% |
| Other Changes | ₹-20.13 Million | -0.19% |
| Total Change | ₹- | 6.41% |
Book Value vs Market Value Analysis
This analysis compares TTK Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.12x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 33.17x to 1.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-03-31 | ₹25.54 | ₹847.40 | x |
| 2006-03-31 | ₹25.85 | ₹847.40 | x |
| 2007-03-31 | ₹34.02 | ₹847.40 | x |
| 2008-03-31 | ₹40.60 | ₹847.40 | x |
| 2009-03-31 | ₹43.98 | ₹847.40 | x |
| 2010-03-31 | ₹45.80 | ₹847.40 | x |
| 2011-03-31 | ₹53.64 | ₹847.40 | x |
| 2012-03-31 | ₹62.11 | ₹847.40 | x |
| 2013-03-31 | ₹69.56 | ₹847.40 | x |
| 2014-03-31 | ₹75.73 | ₹847.40 | x |
| 2015-03-31 | ₹83.76 | ₹847.40 | x |
| 2016-03-31 | ₹96.47 | ₹847.40 | x |
| 2017-03-31 | ₹106.82 | ₹847.40 | x |
| 2018-03-31 | ₹164.88 | ₹847.40 | x |
| 2019-03-31 | ₹177.94 | ₹847.40 | x |
| 2020-03-31 | ₹176.22 | ₹847.40 | x |
| 2021-03-31 | ₹208.53 | ₹847.40 | x |
| 2022-03-31 | ₹233.28 | ₹847.40 | x |
| 2023-03-31 | ₹674.72 | ₹847.40 | x |
| 2024-03-31 | ₹708.36 | ₹847.40 | x |
| 2025-03-31 | ₹753.75 | ₹847.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TTK Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.67%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.36%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 1.20x
- Recent ROE (7.67%) is below the historical average (13.92%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -5.74% | -1.35% | 1.65x | 2.58x | ₹-56.77 Million |
| 2006 | 5.49% | 1.07% | 2.04x | 2.51x | ₹-16.47 Million |
| 2007 | 6.25% | 1.42% | 2.05x | 2.15x | ₹-18.02 Million |
| 2008 | 21.26% | 6.12% | 1.67x | 2.08x | ₹64.56 Million |
| 2009 | 12.68% | 3.59% | 1.59x | 2.22x | ₹16.65 Million |
| 2010 | 14.11% | 3.62% | 1.63x | 2.39x | ₹26.60 Million |
| 2011 | 19.44% | 4.74% | 1.60x | 2.55x | ₹71.48 Million |
| 2012 | 17.82% | 4.42% | 1.66x | 2.43x | ₹68.59 Million |
| 2013 | 14.46% | 3.72% | 1.82x | 2.13x | ₹43.81 Million |
| 2014 | 11.59% | 2.98% | 1.73x | 2.24x | ₹16.96 Million |
| 2015 | 13.66% | 3.35% | 1.75x | 2.33x | ₹43.28 Million |
| 2016 | 16.64% | 4.40% | 1.70x | 2.22x | ₹90.44 Million |
| 2017 | 12.82% | 3.65% | 1.85x | 1.90x | ₹42.50 Million |
| 2018 | 7.80% | 3.15% | 1.41x | 1.75x | ₹-51.32 Million |
| 2019 | 9.69% | 3.89% | 1.51x | 1.65x | ₹-7.69 Million |
| 2020 | 4.95% | 1.91% | 1.49x | 1.73x | ₹-125.80 Million |
| 2021 | 15.76% | 9.76% | 0.96x | 1.68x | ₹169.76 Million |
| 2022 | 12.62% | 6.94% | 1.07x | 1.69x | ₹86.25 Million |
| 2023 | 67.10% | 88.22% | 0.62x | 1.23x | ₹5.44 Billion |
| 2024 | 6.28% | 8.41% | 0.62x | 1.20x | ₹-372.50 Million |
| 2025 | 7.67% | 9.36% | 0.68x | 1.20x | ₹-248.48 Million |
Industry Comparison
This section compares TTK Healthcare Limited's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $6,446,430,401
- Average return on equity (ROE) among peers: 24.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TTK Healthcare Limited (TTKHLTCARE) | ₹10.85 Billion | -5.74% | 0.19x | $31.85 Million |
| GlaxoSmithKline Pharmaceuticals Limited (GLAXO) | $16.96 Billion | 22.18% | 0.80x | $1.19 Billion |
| Kopran Limited (KOPRAN) | $1.09 Billion | 9.86% | 1.43x | $34.19 Million |
| Marksans Pharma Limited (MARKSANS) | $9.05 Billion | 26.35% | 0.36x | $428.52 Million |
| NGL Fine-Chem Limited (NGLFINE) | $160.59 Million | 15.04% | 1.05x | $39.88 Million |
| Pfizer Limited (PFIZER) | $9.01 Billion | 33.25% | 0.22x | $818.67 Million |
| Sanofi India Limited (SANOFI) | $17.36 Billion | 17.53% | 0.46x | $376.73 Million |
| SANOFI CONS HEALTHC IND L (SANOFICONR) | $2.08 Billion | 79.43% | 0.66x | $324.08 Million |
| SENORES PHARMACEUTICALS L (SENORES) | $94.96 Million | 7.21% | 0.53x | $157.65 Million |
| SMS Pharmaceuticals Limited (SMSPHARMA) | $2.22 Billion | 9.19% | 1.30x | $105.56 Million |